Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and ...

RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...

What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Baird currently has a neutral rating on the life sciences company’s stock. ILMN has been the subject of several other reports. Morgan Stanley decreased their price target on shares of Illumina ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Illumina (ILMN). But which of these two stocks is more attractive to value ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

HSBC downgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning, Ratings reports. The brokerage currently has ...

The combination of these factors, along with top-line headwinds from the price and consumable mix, leads Citi analysts to believe that Illumina stock is likely to face continued pressure in the ...